Hydroxychloroquine Use, Preeclampsia, and Preterm Delivery Complications in Systemic Lupus Erythematosus Pregnancies: Is There a Protective Effect?

Documenti analoghi

• Hydroxychloroquine and Pre‐eclampsia in a Diverse Cohort of Women With Systemic Lupus Erythematosus
  di: Julia F. Simard, et al.
  Pubblicazione: (2024)
• Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic
  di: Núria Mercadé‐Besora, et al.
  Pubblicazione: (2024)
• Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring
  di: Stephen Balevic, et al.
  Pubblicazione: (2026)
• Pregnancy Outcomes in a Diverse US Lupus Cohort
  di: Julia F. Simard, et al.
  Pubblicazione: (2024)
• Association Between 25‐hydroxyvitamin D Levels and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus
  di: Nima Madanchi, et al.
  Pubblicazione: (2024)